Introducing the HTRS Institute: Your Topics, Our Experts!

Now available exclusively to HTRS Corporate Colleagues and open to non-member companies after October 15.

For more info, CLICK HERE

 

 

 

Research

Read more

Mentoring

Read more

Workforce Development

Read more

Continuing Education

Read more

ENDURING MATERIALS: HTRS 2021 Scientific Symposium

Jointly provided by Postgraduate Institute for Medicine (PIM) and the Hemostasis and Thrombosis Research Society (HTRS), the HTRS 2021 Enduring Materials will be available for continuing medical education accreditation 1-year post-conference. This activity is supported by independent educational grant from Takeda, CSL Behring, Novo Nordisk, Inc., Grifols, Sanofi Genzyme, Spark Therapeutics, and Pfizer. If you have questions about the HTRS enduring program for CME/CE credit please email [email protected]

Newly Updated Available Credits per Category: Physicians 14.50 credits | Nurses 14.50 credits | APRN 3.50 credits |  Pharmacists 14.50 credits

If you registered to participate in the HTRS 2021 Scientific Symposium virtual conference: You do not need to register again. All HTRS 2021 registrants receive open access to the enduring materials. Please email [email protected] if you need your login credentials.

Access to Enduring Materials for Original HTRS 2021 Registrants/Attendees

Log in with the email address used to register for HTRS 2021 (or the username provided to you by HTRS) and the meeting password you received with your original registration materials. If you forgot your login or need help accessing the portal, email [email protected].

Login to the HTRS 2021 Meeting Site:
https://htrs2021.ims.events/user/login

Direct Link to Enduring Materials (Login Required)
https://htrs2021.ims.events/Scientific-Symposium-On-Demand-Content

Access to Enduring Materials for New Registrants

Registration is now open to access enduring materials for HTRS members and non-members who did not previously register, or attend, the live HTRS 2021 Scientific Symposium. For more info including fees, new registrants should visit www.htrs2021.org. To create a new registration for HTRS 2021: CLICK HERE

HTRS members, visit the Members-Only page on this website for your discount code.  After you register to access enduring materials, HTRS will provide you with login credentials. Enduring materials are available to new registrants until March 14, 2022. 

Click Here to Register:
https://na.eventscloud.com/htrs2021enduring

HTRS Members: Discounted member code for registration
HTRS members  received a discounted member registration code via email. If you have not received the member code, email HTRS at [email protected] to request it. For HTRS members only, you may also find the code in the Members Only section of this website.

HTRS 2021 Scientific Symposium Mailing Lists: SCAM ALERT
Be aware that a company called AppendStarpro is fraudulantly representing HTRS and selling fake attendee lists from the virtual conference. HTRS is not represented by this company or their contact Josey Hollis.  Their outreach is a scam; do not engage.

HTRS would not work with third-party companies to sell mailing lists or any other attendee info.  If you are contacted by a company or individual offering to sell lists on behalf of HTRS, please consult our team first before engaging. Most HTRS sponsorship packages include registrant mailing lists or e-blast campaigns to registrants and/or members depending on the sponsor level. 

If you are interested in purchasing attendee lists, please contact HTRS directly.  Questions?  Email us: [email protected] or [email protected].

 

HTRS 2021 Scientific Symposium Abstracts Now Published in RPTH

The Abstracts from the HTRS 2021 Scientific Symposium are now published in Research and Practice in Thrombosis and Haemostasis (RPTH), the Gold Open Access journal of the International Society on Thrombosis and Haemostasis (ISTH) and the leading journal affiliated with HTRS.

To view the abstracts, CLICK HERE

 

Abstracts from HTRS 2019 Scientific Symposium published in Haemophilia

The Abstracts from the HTRS/NASTH 2019 Scientific Symposium were published in Haemophilia, the official journal of HTRS. 

READ MORE

 

Podcast: NHLBI Resources and Grants for Hematologists

How to maximize research training and funding opportunities for non-malignant hematology and blood science investigators is the subject of this free podcast, in which Dr. Donna DiMichele and Dr. Keith Hoots of the National Heart, Lung, and Blood Institute (NHLBI) talk about NHLBI and National Institutes of Health resources and grants available to hematologists.  

READ MORE

 

Join a Registry

The Children’s Hospital-Acquired Thrombosis (CHAT) Study

 

Department of Health and Human Services, National Institutes of Health and National Heart, Lung, and Blood Institute

RFA-HL-22-004: Application Due on October 19, 2021

An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immunogenicity in Severe Hemophila A: Hemophila A Analytical Cohor Research Program (UG3/UH3 Clinical Trial Not Allowed).

To access website: CLICK HERE

This Funding Opportunity Announcement seeks applications that propose the establishment of a Hemophilia A Analytical Cohort Research Program (HARP) that will:

1) Collaborate with an established consortium of clinical centers to support the recruitment, enrollment, and follow-up of an antenatal/neonatal/ pediatric cohort in severe hemophilia A;

2) Provide data management, laboratory, and biospecimen support necessary for the establishment of a unique and sharable biospecimen resource annotated with robust intergenerational clinical and demographic data to enable future studies of FVIII immunogenicity; and

3) Develop and implement protocols and procedures to conduct hypothesis-driven research studies utilizing data and biospecimens from the antenatal/neonatal/pediatric cohort. The role of HARP is to provide overall project coordination, administration, data and biospecimen management, research protocols and procedures development and implementation, biostatistics/data analytics support; as well as laboratory (including multi-omics) and biorepository expertise for development of this unique intergenerational cohort and resource.

FULL ANNOUNCEMENT

Click HERE for more information or to apply.

 

National Hemophilia Foundation: 'State of the Science Research Summit'

To be held virtually: September 12-15, 2021

Officially endorsed by HTRS, this virtual summit will bring together multi-disciplinary experts from a wide range of fields that shape bleeding disorders research, clinical care, and patient support. Patients, caregivers, and allied community members will join the discussion on six critical themes for research.

For more info, CLICK HERE

 

New 12th Annual Hematology Fellows Consortium

To be held virtually: October 1-3, 2021

New Application Deadline: Friday, September 3rd

On behalf of Program Chairman Dr. Craig Kessler, we invite you to nominate your fellows to apply for this exclusive educational retreat dedicated to the ongoing development and career advancement for fellows with an interest in non-malignant hematology, specifically hemostasis and thrombosis. This program is endorsed by the Hemostasis & Thrombosis Research Society, and is being sponsored by Bayer HealthCare Pharmaceuticals and Spark Therapeutics. 

For more info, check your HTRS email and search "Hematology Fellows Consortium" or email [email protected].

To apply, CLICK HERE

 

ATHN Data Summit 2021

To be held virtually: October 27-29, 2021

Professionals from all ATHN-affiliated centers and collaborating partners will join to reconnect, share ideas, celebrate accomplishments, and advance knowledge on behalf of the blood disorders community.

Registration is free, but you must be registered to receive the access link to join the virtual event.

For more info, CLICK HERE

To register, CLICK HERE

 

HTRS 2021 Abstract Awardees & Research Colloquium Travel Awardees:

Publishing fund, other benefits available 

HTRS Publishing Fund: Abstract awardees from the HTRS 2021 Scientific Symposium and award recipients from the HTRS 2021 Research Colloquium can request HTRS to support the costs to publish their research in the professional journal of their choice through February 9, 2023.  The HTRS Board of Directors and Planning Committees are passionate about this new initiative, as it can help many investigators pay the required publication fees:

  • HTRS can reimburse awardees for the publication costs or pay the publisher directly
  • The limit of funds available for each awardee is up to $2,500 
  • Access to the Publishing Fund expires on February 9, 2023
  • Two ways to apply (payment receipt or publishers' invoice and W-9 required):

HTRS 2021 Scientific Symposium Enduring Materials are Included as part of awardees' complimentary registration.  Visit the Enduring Materials program page for more info and how to access the recordings from HTRS 2021.  If you have questions about the HTRS enduring materials program for CME/CE credit, please email [email protected].

HTRS Membership: Awardees are encouraged to stay connected as Core or Trainee Members!  All Awardees who join or renew their HTRS membership at the Core level are eligible for a 15% discount on their membership dues.  Email [email protected] for the discount code.  (This code is valid for one-year and three-year Core memberships.)  If you are a postdoc, resident, or fellow who has not completed your training program, you are eligible for free Trainee Membership with HTRS for the duration of your training program. 

To learn more about the benefits of HTRS membership, CLICK HERE 

 

HTRS and ISTH Announce Strengthened Collaboration

New official journal affiliation with RPTH

HTRS and the International Society on Thrombosis and Haemostasis (ISTH) are excited to announce a new formalized collaboration to further the missions of both organizations. While our two leading medical research societies have worked together for decades, this strengthened partnership launches several concrete initiatives to further advance care for people with hemostatic and thrombotic disorders.Specifically, an official journal affiliation is newly minted between HTRS anISTH’s Gold Open Access journal, Research and Practice in Thrombosis and Haemostasis (RPTH), featuring these details:

  • RPTH will be listed by HTRS as its leading journal affiliation; however, HTRS will retain its two current journal affiliations with Thrombosis Research and Haemophilia
  • RPTH will publish up to four Mentored Review Articles annually, authored by HTRS-member early career investigator/trainees and their mentors; these articles will undergo peer review, and if accepted will be published as “HTRS Mentored Review Articles”
  • RPTH will publish up to four articles annually, authored by recipients of HTRS research award programs; these articles will also undergo normal peer review and if accepted, they will be published as “HTRS Research Award Articles”

As a key feature in this new alignment, RPTH will publish abstracts accepted to the HTRS biennial Scientific Symposium, beginning with the HTRS 2021 Scientific Symposium recently completed this March.  Starting in 2023, RPTH will publish Illustrated Abstracts prior to the Scientific Symposium, highlighting the contributions of invited speakers. Additional collaboration throughout the year surrounds joint marketing and communications opportunities.

For more info, CLICK HERE

 

Rare Bleeding Disorders Elevated on the National Health Agenda 

New Commitment from National Hemophilia Program Coordinating Center and Treatment Centers

Hemophilia has been named recently as one of only two rare bleeding disorders in Healthy People 2030 (HP2030), identified as a pressing public health issue alongside conditions such as cancer, diabetes, and heart disease.  Released by the U.S. Department of Health and Human Services in August 2020, HP2030 is a focused list of national objectives that aims to track and improve the health and well-being of society over the next decade.

One of these priorities, BDBS-01, will strive to reduce the proportion of people with severe hemophilia who have more than four joint bleeds per year.  Inclusion of BDBS-01 is significant for the hemophilia community. 

"Inclusion of bleeding disorders as a priority on the national health agenda is an important achievement and has resulted from a coordinated, dedicated advocacy by our community," said HTRS Member Amy Shapiro, MD, CEO and co-medical director at the Indiana Hemophilia & Thrombosis Center, Inc., a member HTC within the Great Lakes Regional Hemophilia Network.  "Together with our federal partners and treatment centers across the country, we are committed to achieving this goal."

Data on BDBS-01 is gathered at more than 140 HTCs in the U.S. through the Community Counts: CDC Public Health Surveillance Project for Bleeding Disorders on individuals of all severity of disease.  HTC diligence has assisted in elevating these chronic conditions to a level of national public health awareness.

To learn more, click:

 

Published in Blood Advances

2020 ASH Clinical Practice Guidelines on Treatment of Deep Vein Thrombosis and Pulmonary Embolism

The 2020 ASH Clinical Practice Guidelines on Treatment of Deep Vein Thrombosis and Pulmonary Embolism have been published in Blood Advances.  

To access, CLICK HERE

 

You may also copy and paste the following URL in your browser:

https://ashpublications.org/bloodadvances/article/4/19/4693/463998?_ga=2.258535437.621205929.1602710046-786808430.1599587776

 

2020 ASH ISTH NHF WFH Clinical Practice Guidelines on von Willebrand Disease  

The ASH ISTH NHF WFH Clinical Practice Guidelines on von Willebrand Disease have been published in Blood Advances.

To access, CLICK HERE or download these documents:

HTRS members are also encouraged to review a new proposal for definitions in von Willebrand Disease that was recently published in Blood Advances.

To access this proposal, CLICK HERE.

 

National Institutes of Health Center for Scientific Review

The Center for Scientific Review (CSR) at the National Institutes of Health (NIH) offers two programs that could be valuable for HTRS members:

EARLY CAREER REVIEWER PROGRAM:

Early career scientists who would like review experience can apply to participate in the NIH Early Career Reviewer (ECR) Program. The goals of the ECR Program are to help early career scientists become more competitive as grant applicants through first-hand experience with peer review and to enrich and diversify CSR's pool of trained reviewers.

For more info or to apply to the ECR Program, please CLICK HERE

SCIENTIFIC SOCIETY- REVIEWER RECOMMENDATIONS PORTAL

HTRS members are invited to recommend scientists to serve as grant reviewers through the NIH Review Recommendation portal. Reviewers should be scientists who are generally willing to serve as reviewers and are seen as experts, with integrity, in their field. They should have an active research program, extramural funding, and not currently be a standing member of an NIH study section or advisory council. The NIH is encouraging HTRS to recommend productive scientists from diverse backgrounds and career stages – e.g. assistant, associate, and full professors.

If you would like HTRS to nominate you or a colleague as an NIH reviewer, please email [email protected] for more info.